Search

Now showing items 1-2 of 2

Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of covid-19 pandemic

Karadag, Ömer; Kalyoncu, Umut; Pehlivan, Yavuz; Akar, Servet; Kaşifoglu, Timuçİn; Kimyon, Gezmİs; Dalkilic, Hüseyİn Edİz; Ertenli, Ali İhsan; Kilic, Levent; Ersözlü, Emine Duygu; Bes, Cemal; Emmungil, Hakan; Mercan, Ridvan; Ediboglu, Elİf; Alpay Kanitez, Nilüfer; Bilgin, Emre; Çolak, Seda; Koca, Süleyman Serdar; Gönüllü, Emel; Kücüksahİn, Orhan; Nihan Coskun, Belkis; Yagiz, Burcu; Kiraz, Sedat (Turk J Med Sci, 2021-02-22)

To evaluate treatment adherence and predictors of drug discontinuation among patients with inflammatory arthritis receiving bDMARDs within the first 100 days after the announcement of COVID-19 pandemic. Method: A total of ...

Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis

Gercik, Onay; Bilgin, Emre; Solmaz, Dilek; Cakalagaoglu, Fulya; Saglam, Arzu; Aybi, Ozge; Kardas, Riza Can; Soypacaci, Zeki; Kabadayi, Gokhan; Yildirim, Tolga; Kurut Aysin, Idil; Karadag, Omer; Akar, Servet (BMJ, 2020-05-01)

In patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and renal involvement, the development of end-stage renal disease (ESRD) remains an undesired issue. To date, reported predictors of renal ...

Search

Filters

Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of covid-19 pandemic

Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis